Consensus cbdMD, Inc.

Equities

YCBD

US12482W3097

Delayed Nyse Other stock markets 10:37:57 2024-07-05 am EDT			5-day change	1st Jan Change
0.6 ^USD	+3.43%		+1.69%	-42.31%

May. 15	Earnings Flash (YCBD) CBDMD Reports Q2 Revenue $4.4M	MT
May. 15	CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

Evolution of the average Target Price on cbdMD, Inc.

Price target over the last 5 years

History of analyst recommendation changes

10eb5b7dd6bcce6ad4073e7a3ad82.3ILthw-XQDjoPzoYKba_BziSAtFeo3AvrektBPd4yqs.trGg8DryOnCqBlhCat34YQ3HO7QX8z5n6aVjSZkavNit9Iu2Za42d516XQ~8ced607cd7cc07a131df5aa35e05e5d7

Analyst Recommendations on cbdMD, Inc.

Maxim Starts Coverage on cbdMD with Buy Rating, $3 Price Target	23-10-05	MT
CBDMD : Cantor Fitzgerald Adjusts Price Target for cbdMD to $3.25 from $4.10, Maintains Neutral Rating	21-06-18	MT